Clinical Study
Performance of a New HPV Cervi-Collect Collection and Transportation Kit
Table 3
Correlation between Abbott RealTime HR HPV with Cervi-Collect and Hybrid Capture 2 with PreservCyt L-Pap Samples.
| |||||||||||||||||||||||||||
Positive Agreement—75.3% (70/93); Negative agreement—81.6% (102/125); Overall agreement—88.2% (172/195) (kappa = 0.76). |